About
Technology
Issues
FAQ
Links
Official Page
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.